Related Experiment Videos
Expression and purification of functional recombinant meningococcal transferrin-binding protein A
Jonathan S Oakhill1, Christopher L Joannou, Susan K Buchanan
1Metalloprotein Research Group, The Randall Centre for Molecular Mechanisms of Cell Function, King's College London, London SE1 1UL, UK.
The Biochemical Journal
|April 26, 2002
Summary
Pathogenic bacteria use transferrin-binding protein A (TbpA) for iron uptake. Researchers optimized a method to produce functional TbpA, crucial for developing a universal meningococcal vaccine.
Area of Science:
- Microbiology
- Immunology
- Structural Biology
Background:
- Pathogenic Neisseria bacteria utilize a siderophore-independent iron uptake system involving direct interaction with human transferrin (hTf).
- This system relies on two surface-exposed proteins: TbpA and TbpB. TbpA, a conserved porin-like protein, is a potential vaccine target.
Purpose of the Study:
- To optimize the production of purified, functionally active recombinant TbpA.
- To enable detailed studies of ligand-receptor interactions for vaccine development.
Main Methods:
- Optimization of a procedure for recombinant TbpA expression and purification.
- Assessment of protein activity and stability.
Main Results:
- A reproducible method for obtaining purified, functionally active recombinant TbpA was established.
- The optimized procedure yields sufficient levels and stability for further research.
Conclusions:
- The developed method provides the necessary recombinant TbpA for investigating interactions with human transferrin.
- This is a critical step towards developing a broadly protective meningococcal vaccine targeting TbpA.